CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential

CH Koh, S Lee, M Kwak, BS Kim… - Experimental & Molecular …, 2023 - nature.com
CD8 T cells play crucial roles in immune surveillance and defense against infections and
cancer. After encountering antigenic stimulation, naïve CD8 T cells differentiate and acquire …

IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?

Y Zhao, K Wei, H Chi, Z Xia, X Li - Frontiers in Immunology, 2022 - frontiersin.org
Cancer vaccines exhibit specificity, effectiveness, and safety as an alternative
immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid …

Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade

Y Zhang, RN Sriramaneni, PA Clark… - Nature …, 2022 - nature.com
Radiation therapy (RT) activates an in situ vaccine effect when combined with immune
checkpoint blockade (ICB), yet this effect may be limited because RT does not fully optimize …

Research progress on tumor hypoxia-associative nanomedicine

XX Xu, SY Chen, NB Yi, X Li, SL Chen, Z Lei… - Journal of Controlled …, 2022 - Elsevier
Hypoxia at the solid tumor site is generally related to the unrestricted proliferation and
metabolism of cancerous cells, which can cause tumor metastasis and aggravate tumor …

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells

J Li, Z Xiao, D Wang, L Jia, S Nie, X Zeng, W Hu - Molecular Cancer, 2023 - Springer
Recent advances in neoantigen research have accelerated the development of tumor
immunotherapies, including adoptive cell therapies (ACTs), cancer vaccines and antibody …

Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast cancer: a phase 1 …

MLN Disis, KA Guthrie, Y Liu, AL Coveler… - JAMA …, 2023 - jamanetwork.com
Importance High levels of ERBB2 (formerly HER2)–specific type 1 T cells in the peripheral
blood are associated with favorable clinical outcomes after trastuzumab therapy; however …

Peripheral blood-based biomarkers for immune checkpoint inhibitors

HJ An, HJ Chon, C Kim - International journal of molecular sciences, 2021 - mdpi.com
As cancer immunotherapy using immune checkpoint inhibitors (ICIs) is rapidly evolving in
clinical practice, it is necessary to identify biomarkers that will allow the selection of cancer …

CD8+ T cell metabolic rewiring defined by scRNA-seq identifies a critical role of ASNS expression dynamics in T cell differentiation

J Fernandez-Garcia, F Franco, S Parik… - Cell Reports, 2022 - cell.com
T cells dynamically rewire their metabolism during an immune response. We applied single-
cell RNA sequencing to CD8+ T cells activated and differentiated in vitro in physiological …

pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer

SW Zhu, M Ye, X Ma, ZZ Wu, SC Wan, SC Yang, H Li… - Acta Biomaterialia, 2022 - Elsevier
As the prominent feature of the development and progression of head and neck squamous
cell carcinoma (HNSCC) is immunosuppression, therapeutic strategies to restore antitumor …

Harnessing engineered immune cells and bacteria as drug carriers for cancer immunotherapy

J Jiang, Y Huang, Z Zeng, C Zhao - ACS nano, 2023 - ACS Publications
Immunotherapy continues to be in the spotlight of oncology therapy research in the past few
years and has been proven to be a promising option to modulate one's innate and adaptive …